2024 annual financial data
Seaport Therapeutics 2024 Operating margin
Seaport Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -52,416,000 USD and net income was -46,879,000 USD.
Operating cash flow was -29,629,000 USD.
Get free Seaport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -52,416,000 USD
- Net income
- -46,879,000 USD
- Operating cash flow
- -29,629,000 USD